Oncology Firm TransCode Therapeutics Looks To Raise US$25 Million In IPO
Oncology company TransCode Therapeutics, Inc. is set to begin publicly trading its equityon the Nasdaq Capital Market today under the
Read moreOncology company TransCode Therapeutics, Inc. is set to begin publicly trading its equityon the Nasdaq Capital Market today under the
Read more